Invited Speakers
  • Joan M Bathon
    Columbia Univ.
    USA
  • Dr Bathon is a rheumatologist, Professor of Medicine (tenured), and immediate past Chief of the Division of Rheumatology at Columbia University College of Physicians and Surgeons.
    Dr Bathon’s career has focused on understanding the pathogenesis and functional consequences of inflammation in rheumatoid arthritis (RA), particularly on the extraarticular phenotype of RA, as manifested by accelerated atherosclerosis and myocardial dysfunction. Current work focuses on defining prevalence and risk factors associated with altered left ventricular structure and function in RA, using state-of-the-art cardiac PET/CT scanning. She and Dr Daniel Solomon recently completed a National Institutes of Health (NIH) funded randomized clinical trial to investigate the effect of RA treatments on vascular inflammation, also measured by PET/CT scanning.

    Additional work focuses on defining genetic, protein and cellular biomarkers to identify RA patients at highest risk for cardiovascular disease. She has also played a major role in clinical trials in RA, both NIH and industry sponsored, that brought multiple biologic therapies to clinical use. Her work has consistently been funded by the NIH and other sources. She has authored over 250 scientific publications and book chapters.

    Dr Bathon is a recent member of the National Institute of Arthritis, Musculoskeletal and Skin (NIH-NIAMS) Advisory Council. She also recently served as Co-Chair of the Clinical Trials Working Group of NIAMS. She previously served as a standing member of two NIH study sections.
    She was Editor-in-Chief of Arthritis & Rheumatology, from 2010-15. She is a past member of the Arthritis Advisory Committee of the US Food and Drug Administration (FDA), and a past member of the Board of Directors of the American College of Rheumatology (ACR). Her dedication to advancing the careers of women faculty and trainees is reflected by her recent role at Columbia University as Advisory Dean for Clinician Scientist Faculty, and previously at Johns Hopkins as Director of the Dean’s Office of Women in Science and Medicine, Co-Chair of the Women’s Leadership Council, and Chair of the Department of Medicine’s Task Force on Academic Careers of Women in Medicine.
    She is also deeply committed to promoting diversity and is a founding and current member of the Columbia Dept of Medicine’s Diversity Committee.
    Research & Clinical Focus

    Rheumatoid arthritis

    Cardiovascular co-morbidities

    Inflammation and biomarkers

  • Date Time Room Session Title Lecture Title
    May 16 15:30-16:00 Room 1 (3F) International Symposium 4_Optimizing Treatment Strategies to Mitigate Cardiovascular Risk in Rheumatoid Arthritis Patients Impact of disease-modifying anti-rheumatic drugs on vascular inflammation in rheumatoid arthritis patients